Efficacy of Duhuo Jisheng Decoction for Treating Cold-Dampness Obstruction Syndrome-Type Knee Osteoarthritis: A Pooled Analysis.
Efficacy of Duhuo Jisheng Decoction for Treating Cold-Dampness Obstruction Syndrome-Type Knee Osteoarthritis: A Pooled Analysis.
复制标题
独活寄生汤治疗寒湿痹阻证型膝骨关节炎疗效的汇总分析
DOI:
10.1155/2022/2350404
复制
发表时间:
2022
影响因子:
--
通讯作者:
Liu, Jun
中科院分区:
文献类型:
--
作者:
Zhao, Jinlong;Liang, Guihong;Pan, Jianke;Yang, Weiyi;Zeng, Lingfeng;Liu, Jun
The aim of this study is to provide evidence of the effect of Duhuo Jisheng decoction (DHJSD) on knee osteoarthritis (KOA) of the cold-dampness obstruction syndrome type. We searched PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure, the Wanfang database, and the China Biology Medicine for randomized controlled trials (RCTs) evaluating DHJSD or DHJSD combined with other conventional therapies (DHJSD group) compared to conventional therapy (control group) for cold-dampness obstruction syndrome-type KOA. We calculated the pooled odds ratio (OR), mean difference (MD), and 95% confidence interval (CI) using fixed- or random-effects models. Eleven RCTs, with a total of 895 patients, were included. The results showed that DHJSD could significantly improve the effective rate (OR = 3.13, 95%CI = 2.07 to 4.72, P < 0.001), reduce both the WOMAC (MD = −12.06, 95%CI = -16.34 to -7.79, P < 0.001) and VAS (MD = −1.02, 95%CI = -1.54 to -0.50, P = 0.0001) scores, and reduce the serum IL-6 (MD = −0.80, 95%CI = -0.90 to -0.69, P < 0.001) and TNF-α (MD = −2.49, 95%CI = -2.77 to -2.21, P < 0.001) levels during the treatment of cold-dampness obstruction syndrome-type KOA. The subgroup analysis showed that compared with glucosamine sulfate (GS) alone, DHJSD combined with GS significantly improved the effective rate (OR = 2.59, 95%CI = 1.19 to 5.65, P = 0.02) and reduced the WOMAC (MD = −13.83, 95%CI = -16.14 to -11.51, P < 0.001) and VAS (MD = −0.91, 95%CI = -1.27 to -0.55, P < 0.001) scores. DHJSD + warm-needle acupuncture (WA) lowered the VAS score more than WA alone. There was no significant difference in the decrease in serum IL-1β between the DHJSD and control groups. This study shows that DHJSD can improve the clinical efficacy and reduce the VAS and WOMAC scores in the treatment of cold-dampness obstruction syndrome-type KOA. Compared with GS or WA alone, the combined application of DHJSD with GS or WA could better reduce both the VAS and WOMAC scores.
登录
查看更多内容
影响因子:
5.1
作者:
Vina ER;Kwoh CK
通讯作者:
Kwoh CK
DOI:
10.5435/jaaos-22-04-256
发表时间:
2014-04-01
影响因子:
3.2
作者:
Sanders, James O.;Murray, Jayson;Gross, Leeaht
通讯作者:
Gross, Leeaht
影响因子:
3.4
作者:
Dantas, Lucas Ogura;Salvini, Tania de Fatima;McAlindon, Timothy E.
通讯作者:
McAlindon, Timothy E.
DOI:
10.1155/2020/7275057
发表时间:
2020
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
作者:
Xiao W;Sun W;Lian H;Shen J
通讯作者:
Shen J
影响因子:
5.6
作者:
Liu L;Xu L;Wang S;Wang L;Wang X;Xu H;Li X;Ye H
通讯作者:
Ye H